Abstract

Resealed erythrocytes as carriers for salbutamol sulphate were prepared as a novel drug delivery system for controlled release therepy by hypotonic haemolysis technique. In vitro drug release study was carried out by dialysis technique. The product was lyophillised. In vivo studies in guinea pigs using histamine chamber showed promising results.